Results 211 to 220 of about 43,976 (255)
Some of the next articles are maybe not open access.

Polymyxin — recalled to life

International Journal of Antimicrobial Agents, 2000
In their excellent review on antibiotics in septic shock [1], Periti and Mazzei assign major importance to the elimination of endotoxaemia. In this regard I believe the frequently relegated antibiotic polymyxin deserves some recognition. Originally isolated from Bacillus polymyxa in 1947 polymyxin enjoyed a brief career as an anti-Gram-negative ...
openaire   +2 more sources

Polymyxins and their novel derivatives

Current Opinion in Microbiology, 2010
The emerging very multiresistant Gram-negative bacteria cause remarkable therapeutic challenges. There are no novel classes of agents in clinical development for the treatment of Gram-negative infections. Polymyxins (polymyxin B and colistin) were abandoned in the seventies but are now back in the therapy as the last resort.
openaire   +2 more sources

PHARMACOLOGY OF POLYMYXIN

Annals of the New York Academy of Sciences, 1949
M S, BRYER, E B, SCHOENBACH, E A, BLISS
openaire   +2 more sources

THE CHEMISTRY OF POLYMYXIN A

Annals of the New York Academy of Sciences, 1949
J R, CATCH, T S G, JONES, S, WILKINSON
openaire   +2 more sources

COMPARATIVE BIOLOGICAL STUDIES OF POLYMYXIN A AND POLYMYXIN D

Annals of the New York Academy of Sciences, 1949
G, BROWNLEE, S R M, BUSHBY, E I, SHORT
openaire   +2 more sources

The Polymyxins

Medical Clinics of North America, 1970
openaire   +2 more sources

Polymyxins (Polymyxin B and Colistin)

2010
KEITH S. KAYE, DONALD KAYE
openaire   +1 more source

Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal functions

British Journal of Clinical Pharmacology, 2021
Xu-Ben Yu   +2 more
exaly  

Polymyxins (Polymyxin B and Colistin)

2015
Keith S. Kaye   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy